デフォルト表紙
市場調査レポート
商品コード
1741366

肺がん手術市場:製品種類別、手術の種類別、処置別、がんステージ別、エンドユーザー別、地域別

Lung Cancer Surgery Market, By Product Type, By Surgery Type, By Procedure, By Cancer Stage, By End user, By Geography


出版日
ページ情報
英文 160 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.08円
肺がん手術市場:製品種類別、手術の種類別、処置別、がんステージ別、エンドユーザー別、地域別
出版日: 2025年03月26日
発行: Coherent Market Insights
ページ情報: 英文 160 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

肺がん手術市場は2025年に66億1,000万米ドルと推定され、2032年には90億米ドルに達すると予測され、2025年から2032年までの年間平均成長率(CAGR)は4.5%で成長する見込みです。

分析範囲 分析詳細
基準年 2024年 市場規模 (2025年) 66億1,000万米ドル
実績データ 2020~2024年 予測期間 2025~2032年
予測期間のCAGR (2025~2032年) 4.50% 予測金額 (2032年) 90億米ドル

肺がんは、胸部にある2つのスポンジ状の器官である肺から発生するがんの一種であり、人が息を吸い込むときに酸素を取り込み、息を吐き出すときに二酸化炭素を放出します。肺がんは世界で最もよく見られるがんのひとつであり、がんによる死亡の主な原因となっています。

肺がんの手術は、がんに冒された腫瘍や肺の一部を取り除くために行われる医療処置です。手術の種類は、肺の腫瘍の大きさや位置、肺がんの種類(非小細胞肺がんまたは小細胞肺がん)、患者さんの全身状態によって異なります。肺がん手術には肺葉切除術、肺分節切除術などいくつかの種類があります。肺がん手術は、この攻撃的な疾患を治療するための極めて重要なアプローチです。罹患した肺組織を外科的に切除することで、医療専門家は限局した腫瘍を狙い撃ちし、効果的な治療と治癒の可能性を提供することができます。この手術が成功するかどうかは、早期発見、正確な病期分類、患者の全身状態にかかっています。伝統的な開腹手術からVATS(ビデオ支援胸腔鏡手術)のような低侵襲技術まで、肺がん手術は外傷を最小限に抑え、回復を高めるために進化してきました。肺がん手術は、肺がんに対する集学的な闘いにおいて極めて重要な要素であり続けています。

市場力学:

肺がんの有病率の増加は、予測期間における世界の肺がん手術市場の成長を促進すると予想されます。例えば、世界がん研究基金インターナショナルが2022年3月に発表したデータによると、世界全体では2020年に220万人以上の肺がん新規患者が発生しています。

当レポートの主な特徴

  • 当レポートは、世界の肺がん手術市場を詳細に分析し、2024年を基準年とした予測期間(2025~2032年)の市場規模・CAGRを掲載しています。
  • また、各セグメントの潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて説明しています。
  • また、市場の促進要因・抑制要因や機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
  • 世界の肺がん手術市場における主要企業プロファイルを、企業概要、製品ポートフォリオ、主要なハイライト、財務実績、戦略などの以下のパラメータに基づいて掲載しています。
  • 当レポートの洞察を用いて、マーケティング担当者や企業の経営陣が、将来の製品発売・提携・市場拡大・マーケティング戦術に関する、十分な情報に基づいた意思決定を下すことができます。
  • 「世界の肺がん手術市場」レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界のさまざまな利害関係者に対応しています。
  • 利害関係者は、世界の肺がん手術市場の分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

目次

第1章 分析目的と前提条件

  • 分析目的
  • 前提条件
  • 略語

第2章 市場の展望

  • レポートの説明
    • 市場の定義と範囲
  • エグゼクティブサマリー
  • Coherent Opportunity Map (COM)

第3章 市場力学・規制・動向の分析

  • 市場力学
    • 促進要因
      • 肺がんの罹患率の増加
    • 抑制要因
      • 肺がん手術の高額な費用
    • 機会
      • 低侵襲技術の採用
  • 影響分析
  • 主なハイライト
  • 規制シナリオ
  • 製品の発売/承認
  • PEST分析
  • PORTERの分析
  • 合併と買収のシナリオ

第4章 世界の肺がん手術市場:新型コロナウイルス感染症 (COVID-19) パンデミックの影響

  • COVID-19の疫学
  • 供給側と需要側の分析
  • 経済への影響

第5章 世界の肺がん手術市場:製品種類別(2020~2032年)

  • 手術器具
  • 監視・可視化システム
  • 内視鏡手術機器
  • ロボット支援胸部手術システム
  • その他

第6章 世界の肺がん手術市場:手術の種類別(2020~2032年)

  • 開腹手術
  • 低侵襲手術

第7章 世界の肺がん手術市場:処置別(2020~2032年)

  • 肺葉切除術
  • 分節切除術/楔状切除術
  • 肺切除術
  • スリーブ切除術
  • 拡張切除

第8章 世界の肺がん手術市場:がんステージ別(2020~2032年)

  • 初期ステージ
  • 後期ステージ

第9章 世界の肺がん手術市場:エンドユーザー別(2020~2032年)

  • 病院
  • 外来手術センター
  • 専門クリニック

第10章 世界の肺がん手術市場:地域別(2020~2032年)

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東
  • アフリカ

第11章 競合情勢

  • Ethicon(Johnson & Johnson)
  • Medtronic
  • Intuitive Surgical
  • Olympus Corporation
  • Karl Storz
  • Accuray Incorporated
  • AngioDynamics
  • Varian Medical Systems
  • Siemens Healthineers
  • Atricure, Inc.
  • Novadaq Technologies Inc.
  • GE Healthcare
  • Scanlan International Inc

第12章 セクション

  • 分析手法
  • 出版社について
目次
Product Code: CMI6146

Lung Cancer Surgery Market is estimated to be valued at USD 6.61 Bn in 2025 and is expected to reach USD 9.00 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.5% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 6.61 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 4.50% 2032 Value Projection: USD 9.00 Bn

Lung cancer is a type of cancer that begins in the lungs, which are two spongy organs in chest that take in oxygen when a person inhale and release carbon dioxide when a person exhale. It is one of the most common cancers in the world and is a leading cause of cancer deaths.

Lung cancer surgery is a medical procedure performed to remove a tumor or a portion of the lung affected by cancer. The type of surgery depends on the size and location of the tumor in the lung, the type of lung cancer (non-small cell or small cell lung cancer), and the patient's overall health. There are several types of lung cancer surgeries such as lobectomy, segmentectomy, etc. Lung cancer surgery stands as a pivotal approach to treating this aggressive disease. By surgically removing affected lung tissue, medical professionals can target localized tumors, offering a chance for effective treatment and the potential cure. The procedure's success relies on early detection, accurate staging, and the patient's overall health. From traditional open surgeries to minimally invasive techniques like VATS (Video-Assisted Thoracoscopic Surgery), lung cancer surgery has evolved to minimize trauma and enhance recovery. It remains a crucial component in the multidisciplinary battle against lung cancer.

Market Dynamics:

The increasing prevalence of lung cancer is expected to drive the growth of the global lung cancer surgery market over the forecast period. For instance, according to data published in March 2022 by the World Cancer Research Fund International, globally, there were more than 2.2 million new cases of lung cancer in 2020.

Key features of the study:

  • This report provides in-depth analysis of the global lung cancer surgery market, and provides market size (US$ Bn ) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global lung cancer surgery market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Ethicon (Johnson & Johnson), Medtronic, Intuitive Surgical, Olympus Corporation, Karl Storz, Accuray Incorporated, AngioDynamics, Varian Medical Systems, Siemens Healthineers, Atricure, Inc., Novadaq Technologies Inc., GE Healthcare and Scanlan International Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global lung cancer surgery market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lung cancer surgery market

Lung cancer surgery market Detailed Segmentation:

  • By Product Type:
    • Surgical Instruments
    • Monitoring & Visualizing System
    • Endosurgical Equipment
    • Robotic-Assisted Thoracic Surgery Systems
    • Others
  • By Surgery Type:
    • Open Surgery
    • Minimally Invasive Surgery
  • By Procedure:
    • Lobectomy
    • Segmentectomy/Wedge Resection
    • Pneumonectomy
    • Sleeve Resection
    • Extended Resection
  • By Cancer Stage:
    • Early-Stage
    • Advanced-Stage
  • By End user:
    • Hospitals
    • Ambulatory Surgical Centers
    • Specialty Clinics
  • By Geography:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profile:
    • Ethicon (Johnson & Johnson)
    • Medtronic
    • Intuitive Surgical
    • Olympus Corporation
    • Karl Storz
    • Accuray Incorporated
    • AngioDynamics
    • Varian Medical Systems
    • Siemens Healthineers
    • Atricure, Inc.
    • Novadaq Technologies Inc.
    • GE Healthcare
    • Scanlan International Inc

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Lung Cancer Surgery, By Surgery Type
    • Market Lung Cancer Surgery, By Product Type
    • Market Lung Cancer Surgery, By Procedure
    • Market Lung Cancer Surgery, By Cancer Stage
    • Market Lung Cancer Surgery, By End User
    • Market Lung Cancer Surgery , By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing prevalence of lung cancer
    • Restraints
  • High Cost of Lung Cancer Surgery
    • Opportunities
  • Adoption of Minimally Invasive Techniques
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Lung Cancer Surgery Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Lung Cancer Surgery Market, By Product Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Surgical Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Monitoring & Visualizing System
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Endosurgical Equipment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Robotic-Assisted Thoracic Surgery Systems
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Lung Cancer Surgery Market, By Surgery Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Open Surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Minimally Invasive Surgery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Lung Cancer Surgery Market, By Procedure, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Lobectomy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )
  • Segmentectomy/Wedge Resection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )
  • Pneumonectomy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )
  • Sleeve Resection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )
  • Extended Resection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )

8. Global Lung Cancer Surgery Market, By Cancer Stage, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Early-Stage
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )
  • Advanced-Stage
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

9. Global Lung Cancer Surgery Market, By End User, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Ambulatory Surgical Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )
  • Specialty Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn )

10. Global Lung Cancer Surgery Market, By Geography, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Country 2021 -2032
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Surgery Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Stage, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Surgery Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Stage, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Surgery Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Stage, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Surgery Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Stage, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Surgery Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Stage, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2020 - 2032, (US$ Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Surgery Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Procedure, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Cancer Stage, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
    • Market Size and Forecast, By Country, Y-o-Y Growth and By Country/Region, 2020 - 2032, (US$ Bn)
      • North Africa
      • Central Africa
      • South Africa

11. Competitive Landscape

  • Ethicon (Johnson & Johnson)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medtronic
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Intuitive Surgical
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Olympus Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Karl Storz
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Accuray Incorporated
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • AngioDynamics
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Varian Medical Systems
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Siemens Healthineers
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Atricure, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Novadaq Technologies Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • GE Healthcare
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Scanlan International Inc
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Analyst Views

12. Section

  • Research Methodology
  • About us